HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Heaton, R.K., Clifford, D.B., Franklin, D.R., Woods, S.P., Ake, C., Vaida, F., Ellis, R.J., Letendre, S.L. +19 more·2010·Neurology

Cited by (1,002)

Items 101–200 of 1,002

  1. Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders
    Borjabad, Alejandra, Morgello, Susan, Chao, Wei, Kim, Seon-Young, Brooks, Andrew I., Murray, Jacinta, Potash, Mary Jane, Volsky, David J. · 2011 · PLoS Pathogens
  2. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
    Arvid Edén, Thomas D. Marcotte, Robert K. Heaton, Staffan Nilsson, Henrik Zetterberg, Dietmar Fuchs, Donald R Franklin, Richard W. Price, Igor Grant, Scott Lee Letendre et al. · 2016 · PLoS ONE
  3. Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
    Kesava Rao Venkata Kurapati, Venkata Subba Rao Atluri, Thangavel Samikkannu, Gabriella Garcia, Madhavan Nair · 2016 · Frontiers in Microbiology
  4. HIV-associated neurocognitive disorders
    Montserrat Sanmartí, Laura Ibáñez, Sonia Huertas, Dolors Badenes, David Dalmau, MARK A. SLEVIN, Jerzy Krupiński, Aurel Popa‐Wagner, Ángeles Jaén · 2014 · Journal of Molecular Psychiatry
  5. HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS Study
    Lucette A. Cysique, Kirsten Moffat, Danielle M. Moore, Tammy A. Lane, Nicholas W. S. Davies, Andrew D Carr, Bruce James Brew, Caroline D. Rae · 2013 · PLoS ONE
  6. HIV-Associated Neurocognitive Disorders: A Global Perspective
    Rowan Saloner, Lucette A. Cysique · 2017 · Journal of the International Neuropsychological Society
  7. HIV-1 Tat: Role in Bystander Toxicity
    David Ajasin, Eliseo A. Eugenin · 2020 · Frontiers in Cellular and Infection Microbiology
  8. HIV-associated neurocognitive disorder
    Ruaridh Cameron Smail, Bruce James Brew · 2018 · Handbook of clinical neurology
  9. Neurologic Complications of HIV-1 Infection and Its Treatment in the Era of Antiretroviral Therapy
    Sarah M. Kranick, Avindra Nath · 2012 · CONTINUUM Lifelong Learning in Neurology
  10. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons
    Carmen Teodorof‐Diedrich, Stephen A. Spector · 2018 · Journal of Virology
  11. Prevalence and Factors Associated With Sleep Disturbances Among Early-Treated HIV-Infected Persons
    Nancy F. Crum‐Cianflone, Mollie Poehlman Roediger, David J. Moore, Braden Hale, A. Weintrob, Anuradha Ganesan, Lynn E. Eberly, E. Johnson, Brian K. Agan, Scott Lee Letendre · 2012 · Clinical Infectious Diseases
  12. Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions
    Justin Beardsley, Thuy P. Le · 2015 · Neurology
  13. Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders
    Brian N. Giunta, Jared C. Ehrhart, Demian F. Obregon, Lucy Lam, Lisa Le, Jingji Jin, Francisco Fernandez, Jun Tan, R. Douglas Shytle · 2011 · Molecular Brain
  14. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS
    Amy R. Zipursky, David Gogolishvili, Sergio Rueda, Jason M. Brunetta, Adriana Carvalhal, Jennifer A. McCombe, Michael John Gill, Anita Rachlis, Ron Rosenes, Gordon Arbess et al. · 2013 · AIDS
  15. Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS
    Maria M. Bednar, Christa Buckheit Sturdevant, Lauren A.R. Tompkins, Kathryn T. Arrildt, Elena Dukhovlinova, Laura Pesci Kincer, Ronald I. Swanstrom · 2015 · Current HIV/AIDS Reports
  16. Neuronal toxicity of efavirenz: a systematic review
    Eric H. Decloedt, Gary Maartens · 2013 · Expert Opinion on Drug Safety
  17. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence
    David J. Moore, Kaitlin Blackstone, Steven Paul Woods, Ronald J. Ellis, Joseph Hampton Atkinson, Robert K. Heaton, Igor Grant, the HNRC Group · 2012 · AIDS Care
  18. Poorer Cognitive Performance in Perinatally HIV-Infected Children Versus Healthy Socioeconomically Matched Controls
    Sophie Cohen, Jacqueline A. ter Stege, Gert J. Geurtsen, Henriëtte J. Scherpbier, Taco Willem Kuijpers, Peter Reiss, Ben A. Schmand, Dasja Pajkrt · 2014 · Clinical Infectious Diseases
  19. HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment
    Antonia S. Carroll, Bruce James Brew · 2017 · F1000Research
  20. No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project
    James Howard Cole, Matthan W.A. Caan, Jonathan Underwood, Davide De Francesco, Rosan A van Zoest, Ferdinand W.N.M. Wit, Henk J. M. M. Mutsaerts, Robert Leech, Gert J. Geurtsen, Peter Portegies et al. · 2018 · Clinical Infectious Diseases
  21. Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
    Ronald J. Ellis, María J. Marquine, Marcus Kaul, Jerel Adam Fields, Johannes C. M. Schlachetzki · 2023 · Nature Reviews Neurology
  22. Role of β-Catenin and TCF/LEF Family Members in Transcriptional Activity of HIV in Astrocytes
    Srinivas D. Narasipura, Lisa J. Henderson, Sidney W. Fu, Liang Chen, Fatah Kashanchi, Lena Al‐Harthi · 2011 · Journal of Virology
  23. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment
    Debjani Guha, David R. Lorenz, Vikas Misra, Sukrutha Chettimada, Susan Morgello, Dana H. Gabuzda · 2019 · Journal of Neuroinflammation
  24. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders
    Jennifer L. McGuire, Alexander J. Gill, Steven D. Douglas, Dennis L. Kolson · 2015 · Journal of NeuroVirology
  25. Hormone Replacement Therapy and Risk for Neurodegenerative Diseases
    Richelin V. Dye, Karen J. Miller, Elyse J. Singer, Andrew J. Levine · 2012 · International Journal of Alzheimer s Disease
  26. Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics
    Ankit B. Shah, Mohitkumar R. Gangwani, Nitish S. Chaudhari, Alexy Glazyrin, Hari K. Bhat, Anil Kumar · 2016 · Neurotoxicity Research
  27. Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging
    Alex M. Dickens, Seung Wan Yoo, Alfred C. Chin, Jiadi Xu, Tory P. Johnson, Amanda L. Trout, Kurt F. Hauser, Norman J. Haughey · 2017 · Scientific Reports
  28. Role of Endolysosomes in HIV-1 Tat-Induced Neurotoxicity
    Liang Hui, Xuesong Chen, Norman J. Haughey, Jonathan D. Geiger · 2012 · ASN NEURO
  29. Exosomes and their role in CNS viral infections
    Gavin C. Sampey, Shabana S. Meyering, Mohammad Asad Zadeh, Mohammed Saifuddin, Ramin M. Hakami, Fatah Kashanchi · 2014 · Journal of NeuroVirology
  30. Cross-talk between microglia and neurons regulates HIV latency
    David Alvarez-Carbonell, Fengchun Ye, Nirmala Ramanath, Yoelvis García‐Mesa, Pamela E. Knapp, Kurt F. Hauser, Jonathan Karn · 2019 · PLoS Pathogens
  31. Longitudinal Study of Emerging Mental Health Concerns in Youth Perinatally Infected With HIV and Peer Comparisons
    Kenneth D. Gadow, Konstantia Angelidou, Miriam Chernoff, Paige L. Williams, Jerry Heston, Janice Hodge, Sharon Nachman · 2012 · Journal of Developmental & Behavioral Pediatrics
  32. CCR2 on CD14 + CD16 + monocytes is a biomarker of HIV-associated neurocognitive disorders
    Dionna W. Williams, Desiree Byrd, Leah H. Rubin, Kathryn Anastos, Susan Morgello, Joan W. Berman · 2014 · Neurology Neuroimmunology & Neuroinflammation
  33. Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation
    Fred R. Sattler, Jiaxiu He, Scott Lee Letendre, Cara C. Wilson, Chelsea Sanders, Robert K. Heaton, Ronald J. Ellis, Donald Franklin, Grace M. Aldrovandi, Christina M. Marra et al. · 2014 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  34. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment
    Chaojiang Gu, Alejandra Borjabad, Eran Hadas, Jennifer Kelschenbach, Boe‐Hyun Kim, Wei Chao, Ottavio Arancio, Jin Suh, Bruce Polsky, JoEllyn McMillan et al. · 2018 · PLoS Pathogens
  35. Prefrontal Dopaminergic and Enkephalinergic Synaptic Accommodation in HIV-associated Neurocognitive Disorders and Encephalitis
    Benjamin B. Gelman, Joshua G. Lisinicchia, Tianshen Chen, Kenneth M. Johnson, Kristofer Jennings, Daniel H. Freeman, Vicki M. Soukup · 2012 · Journal of Neuroimmune Pharmacology
  36. Impact of HIV and aging on neuropsychological function
    Lauren A. Wendelken, Victor Valcour · 2012 · Journal of NeuroVirology
  37. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
    Marker, Daniel F, Puccini, Jenna M, Mockus, Taryn E, Barbieri, Justin, Lu, Shao-Ming, Gelbard, Harris A · 2012 · Journal of Neuroinflammation
  38. Enfermedades Infecciosas y Microbiología Clínica
    Diego Viasus, Andrés Antón, Tomàs Pumarola, Jordi Carratalà · 2016
  39. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa
    John A. Joska, Jade Abigail Witten, Kevin G. F. Thomas, Cosette Robertson, Martine Casson-Crook, Heidi Vornbrock Roosa, Jason A. Creighton, Jennifer L. Lyons, Justin C. McArthur, Ned C Sacktor · 2016 · AIDS and Behavior
  40. HIV-associated neurocognitive disorder
    David B. Clifford · 2016 · Current Opinion in Infectious Diseases
  41. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons
    Nancy F. Crum‐Cianflone, David J. Moore, Scott Lee Letendre, Mollie Poehlman Roediger, Lynn E. Eberly, Amy Weintrob, Anuradha Ganesan, Erica N. Johnson, Raechel Del Rosario, Brian K. Agan et al. · 2013 · Neurology
  42. Lower Cognitive Reserve Among Individuals with Syndromic HIV-Associated Neurocognitive Disorders (HAND)
    Erin E. Morgan, Steven Paul Woods, Christine Smith, Erica Weber, James Cobb Scott, Igor Grant · 2012 · AIDS and Behavior
  43. Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
    Zsuzsanna Bohár, József Toldi, Ferenc Fülöp, László Vécsei · 2015 · International Journal of Molecular Sciences
  44. Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study
    Tong Zhu, Jianhui Zhong, Rui Min Hu, Madalina E. Tivarus, SVEN E. EKHOLM, Jaroslaw Harezlak, Hernando Ombao, BRADFORD A. NAVIA, Ron A. Cohen, Giovanni Schifitto · 2012 · Journal of NeuroVirology
  45. An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection
    the HNRP Group, Pariya L. Fazeli, Steven Paul Woods, Robert K. Heaton, Anya Umlauf, Ben D. Gouaux, Debra Rosario Cookson, Raeanne C. Moore, Igor Grant, David J. Moore · 2014 · Journal of NeuroVirology
  46. HIV Infection Is Associated with Attenuated Frontostriatal Intrinsic Connectivity: A Preliminary Study
    Jonathan Ipser, Gregory G. Brown, Amanda Bischoff‐Grethe, Colm G. Connolly, Ronald J. Ellis, Robert K. Heaton, Igor Grant · 2015 · Journal of the International Neuropsychological Society
  47. Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer’s Disease: an Emerging Issue in Geriatric NeuroHIV
    Benedetta Milanini, Victor Valcour · 2017 · Current HIV/AIDS Reports
  48. Immune reconstitution inflammatory syndrome and the central nervous system
    Tory P. Johnson, Avindra Nath · 2011 · Current Opinion in Neurology
  49. New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System
    Victoria Rojas-Celis, Fernando Valiente‐Echeverría, Ricardo Soto‐Rifo, Daniela Toro‐Ascuy · 2019 · Cells
  50. Cardiovascular risk factors and carotid intima‐media thickness are associated with lower cognitive performance in HIV ‐infected patients
    Massimiliano Fabbiani, Nicoletta Ciccarelli, Mariangela Tana, Salvatore Farina, Eleonora Baldonero, Valentina Di Cristo, Manuela Colafigli, Enrica Tamburrini, Roberto Cauda, M. C. Silveri et al. · 2012 · HIV Medicine
  51. Prospective memory deficits are associated with unemployment in persons living with HIV infection.
    Steven Paul Woods, Erica Weber, Bradley M. Weisz, Elizabeth W. Twamley, Igor Grant · 2011 · Rehabilitation Psychology
  52. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era
    Ryan Sanford, Ana Lucia Fernandez Cruz, Susan Combs Scott, Nancy E. Mayo, Lesley K. Fellows, Beau M. Ances, D. Louis Collins · 2017 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  53. Differences in Cognitive Function Between Women and Men With HIV
    Pauline M. Maki, Leah H. Rubin, Gayle Springer, Eric C. Seaberg, Ned C Sacktor, Eric N. Miller, Victor Valcour, Mary Young, James T. Becker, Eileen M Martin · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  54. Lifetime suicidal ideation and attempt are common among HIV+ individuals
    Jayraan Badiee, David J. Moore, Joseph Hampton Atkinson, Florin Vaida, Mickey Gerard, Nichole A. Duarte, Donald R Franklin, Ben D. Gouaux, John Allen McCutchan, Robert K. Heaton et al. · 2011 · Journal of Affective Disorders
  55. Impact of Depression and Inflammation on the Progression of HIV Disease
    Yainyrette Rivera-Rivera, Fabián J Vázquez-Santiago · 2016 · Journal of Clinical & Cellular Immunology
  56. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm
    Lucette A. Cysique, Bruce James Brew · 2019 · Journal of NeuroVirology
  57. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy
    Tanja Su, Ferdinand W.N.M. Wit, Matthan W.A. Caan, J. Schouten, Maria Prins, Gert J. Geurtsen, James Howard Cole, David James Sharp, Edo Richard, Liesbeth Reneman et al. · 2016 · AIDS
  58. Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART
    Catherine R. Cochrane, Thomas A. Angelovich, Sarah J. Byrnes, Emily Waring, Aleks C. Guanizo, Gemma S. Trollope, Jingling Zhou, Judith Vue, Lachlan Senior, Emma Wanicek et al. · 2022 · Annals of Neurology
  59. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection
    Tanja Su, J. Schouten, Gert J. Geurtsen, Ferdinand W.N.M. Wit, Ineke G. Stolte, Maria Prins, Peter Portegies, Matthan W.A. Caan, Peter Reiss, Charles B.L.M. Majoie et al. · 2015 · AIDS
  60. Pathogenesis of age-related HIV neurodegeneration
    Mirosław Mackiewicz, Cassia Overk, Cristian L. Achim, Eliezer Masliah · 2019 · Journal of NeuroVirology
  61. The relationship between HIV and prevalence of disabilities in sub‐Saharan Africa: systematic review (FA)
    Lena Morgon Banks, Maria Zuurmond, Rashida A. Ferrand, Hannah Kuper · 2014 · Tropical Medicine & International Health
  62. CNS reservoirs for HIV: implications for eradication
    Joanna M. Hellmuth, Victor Valcour, Serena Spudich · 2015 · Journal of Virus Eradication
  63. A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia Scale
    Lewis John Haddow, Sian Floyd, Andrew J Copas, Richard J.C. Gilson · 2013 · PLoS ONE
  64. MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology
    Zaikun Xu, Eugene L. Asahchop, William G. Branton, Benjamin B. Gelman, Christopher Power, Tom C. Hobman · 2017 · PLoS Pathogens
  65. Comparison of dementia risk after age 50 between individuals with and without HIV infection
    Jennifer O. Lam, Craig E. Hou, J. Carlo Hojilla, Alexandra N. Anderson, Paola Gilsanz, Stacey Alexeeff, Tory Levine‐Hall, Nicole Hood, Catherine Lee, Derek D. Satre et al. · 2020 · AIDS
  66. Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior
    Yun Kyung Hahn, Elizabeth M. Podhaizer, Sean P. Farris, Michael F. Miles, Kurt F. Hauser, Pamela E. Knapp · 2013 · Brain Structure and Function
  67. Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment
    Jay Rappaport, David J. Volsky · 2015 · Journal of NeuroVirology
  68. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection
    Andrew C. Young, Constantin Theodore Yiannoutsos, Manu Hegde, Evelyn Lee, Julia J. Peterson, Rudy Walter, Richard W. Price, Dieter Johannes Meyerhoff, Serena Spudich · 2014 · Neurology
  69. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)
    Lishomwa C. Ndhlovu, Tracie M Umaki, Glen M. Chew, Dominic Cheung Chow, Melissa Agsalda, Kalpana J. Kallianpur, Robert H. Paul, Guangxiang Zhang, Erika Ho, Nancy Hanks et al. · 2014 · Journal of NeuroVirology
  70. The macrophage: a therapeutic target in HIV-1 infection
    Amit Kumar, Georges Herbein · 2014 · Molecular and Cellular Therapies
  71. Role of Neuroimaging in HIV-Associated Neurocognitive Disorders
    Mary Clare Masters, Beau M. Ances · 2014 · Seminars in Neurology
  72. Psychosocial, mental health, and behavioral issues of aging with HIV
    Sergio Rueda, Stephanie Law, Sean B. Rourke · 2014 · Current Opinion in HIV and AIDS
  73. Does Antiretroviral Therapy Improve HIV-Associated Cognitive Impairment? A Quantitative Review of the Literature
    Timour Al‐Khindi, Konstantine K. Zakzanis, Wilfred G. van Gorp · 2011 · Journal of the International Neuropsychological Society
  74. Residual immune dysfunction under antiretroviral therapy
    Catherine Wen Cai, Irini Sereti · 2021 · Seminars in Immunology
  75. Moving on From HAND: Why We Need New Criteria for Cognitive Impairment in Persons Living With Human Immunodeficiency Virus and a Proposed Way Forward
    Sam Nightingale, Anna J. Dreyer, Deanna R. Saylor, Magnus Gisslén, Alan Winston, John A. Joska · 2021 · Clinical Infectious Diseases
  76. HIV-Associated Neurological Disorders
    Ik Lin Tan, Justin C. McArthur · 2011 · CNS Drugs
  77. Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages
    Peter J. Gaskill, Hideaki Yano, Ganjam V. Kalpana, Jonathan A. Javitch, Joan W. Berman · 2014 · PLoS ONE
  78. Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy
    Alexander J. Gill, Dennis L. Kolson · 2013 · Critical Reviews in Immunology
  79. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria
    Walter Royal, Mariana Cherner, Tricia H. Burdo, Anya Umlauf, Scott Lee Letendre, Jibreel Jumare, Alash’le Abimiku, Peter Alabi, Nura H. Alkali, Sunday A. Bwala et al. · 2016 · PLoS ONE
  80. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND
    Jamie Marino, Monique E. Maubert, Anthony R. Mele, Cassandra Spector, Brian L. Wigdahl, Michael R. Nonnemacher · 2020 · Cellular and Molecular Life Sciences
  81. HIV and Neurocognitive Dysfunction
    Serena Spudich · 2013 · Current HIV/AIDS Reports
  82. Gray and White Matter Abnormalities in Treated Human Immunodeficiency Virus Disease and Their Relationship to Cognitive Function
    Jonathan Underwood, James Howard Cole, Matthan W.A. Caan, Davide De Francesco, Robert Leech, Rosan A van Zoest, Tanja Su, Gert J. Geurtsen, Ben A. Schmand, Peter Portegies et al. · 2017 · Clinical Infectious Diseases
  83. Mapping white matter integrity in elderly people with HIV
    Talia M. Nir, Neda Jahanshad, Edgar Busovaca, Lauren A. Wendelken, Krista Nicolas, Paul M. Thompson, Victor Valcour · 2013 · Human Brain Mapping
  84. The Veterans Aging Cohort Study Index is Associated With Concurrent Risk for Neurocognitive Impairment
    María J. Marquine, Anya Umlauf, Alexandra S. Rooney, Pariya L. Fazeli, Ben D. Gouaux, Steven Paul Woods, Scott Lee Letendre, Ronald J. Ellis, Igor Grant, David J. Moore · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  85. Clinical contributors to cerebral white matter integrity in HIV-infected individuals
    Assawin Gongvatana, Ronald A. Cohen, Stephen Correia, Kathryn N. Devlin, Jadrian Miles, Hakmook Kang, Hernando Ombao, BRADFORD A. NAVIA, David H. Laidlaw, Karen T. Tashima · 2011 · Journal of NeuroVirology
  86. Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy
    Ramona Bhatia, Patrick Ryscavage, Babafemi Taiwo · 2011 · Journal of NeuroVirology
  87. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1–Infected Adults in the United States
    Shibani S. Mukerji, Vikas Misra, David R. Lorenz, Hajime Uno, Susan Morgello, Donald R Franklin, Ronald J. Ellis, Scott Lee Letendre, Dana H. Gabuzda · 2018 · Clinical Infectious Diseases
  88. Successful aging and the epidemiology of HIV
    David E. Vance, Teena Minton McGuinness, Karen Musgrove, Nancy A. Orel, Pariya L. Fazeli · 2011 · Clinical Interventions in Aging
  89. Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide
    Jody Kamminga, Lucette A. Cysique, Grace Lu, Jennifer Batchelor, Bruce James Brew · 2013 · Current HIV/AIDS Reports
  90. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy
    Assawin Gongvatana, Jaroslaw Harezlak, Steven D. Buchthal, Eric S. Daar, Giovanni Schifitto, Thomas Campbell, Michael J. Taylor, Elyse J. Singer, Jeffrey Algers, Jianhui Zhong et al. · 2013 · Journal of NeuroVirology
  91. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy
    Albert M. L. Anderson, José A. Muñoz-Moreno, Daniel R. McClernon, Ronald J. Ellis, Debra Rosario Cookson, David B. Clifford, Ann C. Collier, Benjamin B. Gelman, Christina M. Marra, Justin C. McArthur et al. · 2016 · The Journal of Infectious Diseases
  92. HIV, Tat and dopamine transmission
    Peter J. Gaskill, Douglas R. Miller, Joyonna Gamble‐George, Hideaki Yano, Habibeh Khoshbouei · 2017 · Neurobiology of Disease
  93. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study
    Angela Matinella, Massimiliano Lanzafame, Maria A. Bonometti, Alberto Gajofatto, Ercole Concia, Sandro Vento, Salvatore Monaco, Sérgio Ferrari · 2015 · Journal of Neurology
  94. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults
    the HNRP Group, Catherine A. Dufour, María J. Marquine, Pariya L. Fazeli, Brook L. Henry, Ronald J. Ellis, Igor Grant, David J. Moore · 2013 · Journal of NeuroVirology
  95. Drug Induced Increases in CNS Dopamine Alter Monocyte, Macrophage and T Cell Functions: Implications for HAND
    Peter J. Gaskill, Tina M. Calderon, Jacqueline S. Coley, Joan W. Berman · 2013 · Journal of Neuroimmune Pharmacology
  96. Neurologic disorders incidence in HIV+ vs HIV− men
    Farrah Jasmine Mateen, Russell Taki Shinohara, Marco Carone, Eric N. Miller, Justin C. McArthur, Lisa P. Jacobson, Ned C Sacktor · 2012 · Neurology
  97. Neurobehavioral alterations in HIV-1 transgenic rats: Evidence for dopaminergic dysfunction
    Landhing M. Moran, Rosemarie M. Booze, Katy M. Webb, Charles F. Mactutus · 2012 · Experimental Neurology
  98. Intraindividual variability in HIV infection: Evidence for greater neurocognitive dispersion in older HIV seropositive adults.
    Erin E. Morgan, Steven Paul Woods, Lisa Delano‐Wood, Mark William Bondi, Igor Grant · 2011 · Neuropsychology
  99. Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START ) trial
    EJ Wright, Birgit Grund, Lucette A. Cysique, KR Robertson, Bruce James Brew, Gary Collins, JC Shlay, Alan Winston, Trh Read, Rw Price et al. · 2015 · HIV Medicine
  100. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection
    The TMARC Group, Erica Weber, Erin E. Morgan, Jennifer E. Iudicello, Kaitlin Blackstone, Igor Grant, Ronald J. Ellis, Scott Lee Letendre, Susan J. Little, Sheldon Morris et al. · 2012 · Journal of NeuroVirology